Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
Cerilliant
Novartis
Johnson and Johnson
Daiichi Sankyo
Harvard Business School
US Army
Cipla
Queensland Health
McKesson

Generated: October 17, 2017

DrugPatentWatch Database Preview

Nisoldipine - Generic Drug Details

« Back to Dashboard

What are the generic sources for nisoldipine and what is the scope of nisoldipine freedom to operate?

Nisoldipine
is the generic ingredient in two branded drugs marketed by Mylan and Covis Pharma Bv, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are eight drug master file entries for nisoldipine. Six suppliers are listed for this compound.

Summary for Generic Name: nisoldipine

US Patents:0
Tradenames:2
Applicants:2
NDAs:3
Drug Master File Entries: see list8
Suppliers / Packagers: see list6
Bulk Api Vendors: see list59
Clinical Trials: see list4
Patent Applications: see list6,010
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:nisoldipine at DailyMed

Pharmacology for Ingredient: nisoldipine

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-003Feb 2, 1995DISCNYesNo► Subscribe► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-003Jan 26, 2011RXNoNo► Subscribe► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-002Jan 26, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL079051-003Jul 25, 2008RXNoYes► Subscribe► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL079051-002Jul 25, 2008RXNoYes► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-008Jan 2, 2008ABRXYesYes► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-005Jan 2, 2008ABRXYesYes► Subscribe► Subscribe► Subscribe
Mylan
NISOLDIPINE
nisoldipine
TABLET, EXTENDED RELEASE;ORAL091001-001Jan 26, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-007Jan 2, 2008ABRXYesYes► Subscribe► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-006Jan 2, 2008DISCNYesNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nisoldipine

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-007Jan 2, 2008► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-004Feb 2, 1995► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-005Jan 2, 2008► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-008Jan 2, 2008► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-002Feb 2, 1995► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-005Jan 2, 2008► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-006Jan 2, 2008► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-001Feb 2, 1995► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-004Feb 2, 1995► Subscribe► Subscribe
Covis Pharma Bv
SULAR
nisoldipine
TABLET, EXTENDED RELEASE;ORAL020356-003Feb 2, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Moodys
QuintilesIMS
Merck
Cantor Fitzgerald
Boehringer Ingelheim
Novartis
McKesson
Fuji
Farmers Insurance
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot